INR 23.21
(4.03%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 625.55 Million INR | 24.42% |
2022 | 1.97 Billion INR | -0.16% |
2021 | 1.97 Billion INR | 1.11% |
2020 | 1.95 Billion INR | -6.65% |
2019 | 2.09 Billion INR | -0.63% |
2018 | 2.1 Billion INR | 9.3% |
2017 | 1.92 Billion INR | -3.25% |
2016 | 1.99 Billion INR | 2.98% |
2015 | 1.93 Billion INR | -1.13% |
2014 | 1.95 Billion INR | 8.61% |
2013 | 1.8 Billion INR | 3.14% |
2012 | 1.74 Billion INR | 27.29% |
2011 | 1.37 Billion INR | 45.89% |
2010 | 941.26 Million INR | -8.62% |
2009 | 1.03 Billion INR | -84.82% |
2008 | 6.78 Billion INR | 6.99% |
2007 | 6.34 Billion INR | 55.57% |
2006 | 4.07 Billion INR | 79.18% |
2005 | 2.27 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 581.67 Million INR | -4.65% |
2023 Q2 | 986.17 Million INR | 4.09% |
2023 FY | 2.45 Billion INR | 24.42% |
2023 Q1 | 947.41 Million INR | 221.35% |
2023 Q4 | 610.04 Million INR | -37.74% |
2023 Q3 | 979.84 Million INR | -0.64% |
2022 Q4 | -780.7 Million INR | -189.68% |
2022 FY | 1.97 Billion INR | -0.16% |
2022 Q1 | 862.94 Million INR | 258.02% |
2022 Q2 | 1.02 Billion INR | 18.41% |
2022 Q3 | 870.5 Million INR | -14.81% |
2021 Q4 | -546.08 Million INR | -163.77% |
2021 FY | 1.97 Billion INR | 1.11% |
2021 Q3 | 856.37 Million INR | -1.74% |
2021 Q2 | 871.55 Million INR | 9.57% |
2021 Q1 | 795.43 Million INR | 263.92% |
2020 Q4 | -485.26 Million INR | -159.64% |
2020 Q1 | 817.77 Million INR | 259.04% |
2020 Q3 | 813.6 Million INR | 0.63% |
2020 Q2 | 808.52 Million INR | -1.13% |
2020 FY | 1.95 Billion INR | -6.65% |
2019 Q1 | 866.59 Million INR | 247.63% |
2019 Q3 | 850.98 Million INR | -4.54% |
2019 FY | 2.09 Billion INR | -0.63% |
2019 Q4 | -514.21 Million INR | -160.42% |
2019 Q2 | 891.5 Million INR | 2.87% |
2018 Q3 | 962.33 Million INR | 8.43% |
2018 Q1 | 845.4 Million INR | 0.0% |
2018 Q4 | -587 Million INR | -161.0% |
2018 FY | 2.1 Billion INR | 9.3% |
2018 Q2 | 887.52 Million INR | 4.98% |
2017 FY | 1.92 Billion INR | -3.25% |
2016 FY | 1.99 Billion INR | 2.98% |
2015 Q3 | - INR | 0.0% |
2015 FY | 1.93 Billion INR | -1.13% |
2014 FY | 1.95 Billion INR | 8.61% |
2014 Q3 | - INR | 0.0% |
2013 FY | 1.8 Billion INR | 3.14% |
2012 FY | 1.74 Billion INR | 27.29% |
2011 FY | 1.37 Billion INR | 45.89% |
2010 FY | 941.26 Million INR | -8.62% |
2009 FY | 1.03 Billion INR | -84.82% |
2008 FY | 6.78 Billion INR | 6.99% |
2007 FY | 6.34 Billion INR | 55.57% |
2006 FY | 4.07 Billion INR | 79.18% |
2005 FY | 2.27 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 96.058% |
Aurobindo Pharma Limited | 39.23 Billion INR | 98.406% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 94.626% |
Granules India Limited | 7.18 Billion INR | 91.29% |
Indoco Remedies Limited | 4.74 Billion INR | 86.827% |
Achyut Healthcare Limited | 1.6 Million INR | -38778.185% |
Ajanta Pharma Limited | 30.46 Billion INR | 97.947% |
Alkem Laboratories Limited | 32.83 Billion INR | 98.095% |
Alpa Laboratories Limited | 156.14 Million INR | -300.616% |
Brooks Laboratories Limited | 51.18 Million INR | -1122.255% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 75.944% |
Bajaj HealthCare Limited | 985.34 Million INR | 36.515% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 55.923% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.348% |
Eris Lifesciences Limited | 4.94 Billion INR | 87.345% |
FDC Limited | 5.34 Billion INR | 88.304% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.074% |
Gufic Biosciences Limited | 1.07 Billion INR | 41.956% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 70.551% |
Ipca Laboratories Limited | 13.91 Billion INR | 95.504% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 19.118% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1255.295% |
Lasa Supergenerics Limited | 291.17 Million INR | -114.837% |
Laurus Labs Limited | 3.01 Billion INR | 79.223% |
Lupin Limited | 95.67 Billion INR | 99.346% |
Mankind Pharma Limited | 23.15 Billion INR | 97.298% |
Medicamen Biotech Limited | 335.16 Million INR | -86.638% |
Medico Remedies Limited | 161.84 Million INR | -286.514% |
Megasoft Limited | 49.52 Million INR | -1163.023% |
NATCO Pharma Limited | 10.05 Billion INR | 93.781% |
Piramal Pharma Limited | 19.91 Billion INR | 96.859% |
RPG Life Sciences Limited | 1.63 Billion INR | 61.752% |
Sigachi Industries Limited | 579.88 Million INR | -7.874% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.594% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 55.407% |
Syncom Formulations (India) Limited | 942.39 Million INR | 33.622% |
Unichem Laboratories Limited | 6.72 Billion INR | 90.699% |
Wanbury Limited | 1.16 Billion INR | 46.116% |
Windlas Biotech Limited | 1 Billion INR | 37.85% |
ZIM Laboratories Limited | 1.01 Billion INR | 38.251% |
Zydus Lifesciences Limited | 43.17 Billion INR | 98.551% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 79.669% |
Divi's Laboratories Limited | 14.17 Billion INR | 95.585% |
Hester Biosciences Limited | 908.84 Million INR | 31.171% |
Procter & Gamble Health Limited | 2.99 Billion INR | 79.116% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 43.079% |
Bal Pharma Limited | 389.89 Million INR | -60.443% |
Strides Pharma Science Limited | 9.16 Billion INR | 93.173% |
Venus Remedies Limited | 1.91 Billion INR | 67.356% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 79.653% |
Shilpa Medicare Limited | 2.18 Billion INR | 71.313% |
Aarti Drugs Limited | 1.16 Billion INR | 46.419% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 43.07% |
Suven Life Sciences Limited | 109.75 Million INR | -469.977% |
Ind-Swift Limited | 946.56 Million INR | 33.914% |
Valiant Laboratories Limited | 36.28 Million INR | -1623.801% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 92.568% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 86.341% |
Themis Medicare Limited | 782.85 Million INR | 20.094% |
Hikal Limited | 2.48 Billion INR | 74.841% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 97.08% |
Sequent Scientific Limited | 2.9 Billion INR | 78.443% |
Novartis India Limited | 470.1 Million INR | -33.067% |
Wockhardt Limited | 6.4 Billion INR | 90.226% |
Jubilant Pharmova Limited | 14.45 Billion INR | 95.672% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -3759.109% |
Neuland Laboratories Limited | 2.92 Billion INR | 78.648% |
Morepen Laboratories Limited | 1.98 Billion INR | 68.525% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -51.675% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | 7.483% |